Literature DB >> 16615110

No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: result from a cross-sectional study in a high-risk region of China.

Guo-Fu Gao1, Mark J Roth, Wen-Qiang Wei, Christian C Abnet, Feng Chen, Ning Lu, Fang-Hui Zhao, Xin-Qing Li, Guo-Qing Wang, Philip R Taylor, Qin-Jing Pan, Wen Chen, Sanford M Dawsey, You-Lin Qiao.   

Abstract

Esophageal cancer is a leading cause of cancer death, especially in developing countries. In high-risk regions, squamous cell carcinoma is the most common type of esophageal cancer, and its etiology remains poorly understood. The purpose of this study was to evaluate the association between human papillomavirus (HPV) infection and esophageal squamous cell carcinoma (ESCC) and related precursor lesions in a high-risk area of China. We conducted a cross-sectional study among adult inhabitants of Linxian, China. All subjects were interviewed about potential risk factors, had the length of their esophagus sampled by a balloon cytology examination and underwent endoscopy with mucosal iodine staining and biopsy of all unstained lesions. A multivalent HPV hybridization probe, Digene Hybrid Capture II (Gaithersburg, MD), which recognizes high-risk types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68, was used to determine the HPV infection status of the cytologic specimens, and the endoscopic biopsies were used to classify each subject's esophageal disease. 740 subjects completed the cytologic and endoscopic exams, and 702 had adequate cytologic and biopsy specimens. Using a cutpoint of > or =3.0 pg/ml of HPV DNA to define a positive test, HPV positivity was identified in 13% (61/475) of subjects without squamous dysplasia, 8% (8/102) with mild dysplasia, 7% (6/83) with moderate dysplasia, 16% (6/38) with severe dysplasia and zero (0/4) with invasive ESCC. Changing the cutpoint defining a positive test did not change the association of HPV infection and dysplasia grade. In this high-risk population, infection of esophageal cells with high-risk HPV types occurs in 13% of asymptomatic adults with no evidence of squamous dysplasia and a similar proportion of individuals with mild, moderate or severe dysplasia. This suggests that HPV infection is not a major risk factor for ESCC in this high-risk Chinese population. Further studies are warranted to determine if infection with this agent is associated with neoplastic progression in a subset of cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16615110     DOI: 10.1002/ijc.21980

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

Review 2.  The role of viral and bacterial pathogens in gastrointestinal cancer.

Authors:  Michael Selgrad; Peter Malfertheiner; Lucia Fini; Ajay Goel; C Richard Boland; Luigi Ricciardiello
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

3.  Squamous dysplasia--the precursor lesion for esophageal squamous cell carcinoma.

Authors:  Philip R Taylor; Christian C Abnet; Sanford M Dawsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

4.  The absence of human papillomavirus in esophageal squamous cell carcinoma in East China.

Authors:  Haohua Teng; Xiaojing Li; Xiuping Liu; Jie Wu; Jie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Human papillomavirus in upper digestive tract tumors from three countries.

Authors:  Andres Castillo; Chihaya Koriyama; Michiyo Higashi; Muhammad Anwar; Mulazim Hussain Bukhari; Edwin Carrascal; Lida Mancilla; Hiroshi Okumura; Masataka Matsumoto; Kazumasa Sugihara; Shoji Natsugoe; Yoshito Eizuru; Suminori Akiba
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

6.  Prevalence of human papillomavirus in esophageal carcinoma in Tangshan, China.

Authors:  Mohammadreza Mohammadzad Mehryar; Shu-Ying Li; Hong-Wei Liu; Fan Li; Fang Zhang; Yu-Bai Zhou; Yi Zeng; Jin-Tao Li
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

7.  Detection of human papillomavirus DNA in esophageal carcinoma in Greece.

Authors:  Georgios Georgantis; Theodoros Syrakos; Theodoros Agorastos; Spiridon Miliaras; Asterios Gagalis; Georgios Tsoulfas; Konstantinos Spanos; Georgios Marakis
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

8.  No evidence of HPV DNA in esophageal squamous cell carcinoma in a population of Southern Brazil.

Authors:  Luís Carlos Moreira Antunes; João Carlos Prolla; Antonio de Barros Lopes; Marta Pires da Rocha; Renato Borges Fagundes
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

9.  Human papillomavirus and the risk of Barrett's esophagus.

Authors:  H B El-Serag; J M Hollier; P Gravitt; A Alsarraj; M Younes
Journal:  Dis Esophagus       Date:  2012-08-14       Impact factor: 3.429

10.  Human papilloma virus and esophageal carcinoma in a Latin-American region.

Authors:  Roberto Herrera-Goepfert; Marcela Lizano; Suminori Akiba; Adela Carrillo-García; Mauricio Becker-D'Acosta
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.